Pharmacodynamics (PD), Pharmacokinetics (PK) and PK-PD Modeling of NRF2 Activating Dietary Phytochemicals in Cancer Prevention and in Health
Current Pharmacology Reports · 05.12.2024 · 11 (1)
DOI: 10.1007/s40495-024-00388-6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Pharmacology Reports, online erschienen am 05.12.2024. Verfasst von Ahmad Shannar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 088…. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 187 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIEHS NIH HHS, NCCIH NIH HHS, National Center for Complementary and Integrative Health.
Abstract (Originalsprache)
Purpose of Review Dietary phytochemicals, bioactive compounds derived from plants, have gained increasing attention for their potential role in cancer prevention. Among these, NRF2 (nuclear factor erythroid 2–related factor 2) activating dietary phytochemicals such as curcumin, sulforaphane, ursolic acid, and cyanidin have demonstrated significant antioxidant and anti-inflammatory properties, making them promising agents in chemoprevention. This review examines the pharmacokinetic (PK) and pharmacodynamic (PD) profiles of these dietary phytochemicals, with a focus on their NRF2-mediated effects in cancer prevention. Recent Findings Preclinical studies have highlighted the potential of these dietary phytochemicals to modulate oxidative stress and inflammation, key drivers of carcinogenesis. We explore the complexity of their PK/PD properties, influenced by factors such as bioavailability, metabolism, and drug interactions. While most of these phytochemicals follow two compartmental PK, their anti-oxidant and anti-inflammatory effects follow the indirect response (IDR) model. Furthermore, we discuss the application of physiologically based pharmacokinetic (PBPK) modeling to simulate the behavior of these compounds in humans, providing insights for clinical translation. Summary The integration of PK-PD analysis into the development of dietary phytochemical-based therapies offers a pathway to optimize dosing strategies, enhance therapeutic efficacy, and improve safety. This review underscores the importance of these compounds as part of cancer interception strategies, particularly in the early stages of cancer development, where they may offer a natural, less toxic alternative to conventional therapies. Graphical Abstract
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutics, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 160 Frelinghuysen Road, Piscataway, NJ 08854 USA.
- Graduate Program in Pharmaceutical Sciences, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, NJ 08854 USA.
Förderung
- NIEHS NIH HHS
- NCCIH NIH HHS
- National Center for Complementary and Integrative Health
- National Institute of Environmental Health Sciences
Zitieren
APA
Shannar, A., Chou, P. J., Peter, R., Dave, P. D., Patel, K., Pan, Y., Xu, J., Sarwar, M. S., & Kong, A. N. (2024). Pharmacodynamics (PD), Pharmacokinetics (PK) and PK-PD Modeling of NRF2 Activating Dietary Phytochemicals in Cancer Prevention and in Health. Current Pharmacology Reports, 11(1). https://doi.org/10.1007/s40495-024-00388-6
Vancouver
Shannar A, Chou PJ, Peter R, Dave PD, Patel K, Pan Y, et al. Pharmacodynamics (PD), Pharmacokinetics (PK) and PK-PD Modeling of NRF2 Activating Dietary Phytochemicals in Cancer Prevention and in Health. Current Pharmacology Reports. 2024;11(1). doi:10.1007/s40495-024-00388-6
BibTeX
@article{Shannar2024,
author = {Shannar, Ahmad and Chou, Pochung Jordan and Peter, Rebecca and Dave, Parv Dushyant and Patel, Komal and Pan, Yuxin and Xu, Jiawei and Sarwar, Md Shahid and Kong, Ah-Ng},
title = {Pharmacodynamics (PD), Pharmacokinetics (PK) and PK-PD Modeling of NRF2 Activating Dietary Phytochemicals in Cancer Prevention and in Health},
journal = {Current Pharmacology Reports},
year = {2024},
volume = {11},
number = {1},
doi = {10.1007/s40495-024-00388-6}
}
EUVIMED